Gastrointestinal pharmacology

Veterinary Clinics of North America - Small Animal Practice

Volumn 29, Issue 2, 1999, Pages 343-376

  Boothe, D M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ATROPINE; BISACODYL; BUTYROPHENONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; COLESTYRAMINE; CYPROHEPTADINE; CYTOCHROME P450; DROPERIDOL; GLUCOCORTICOID; HALOPERIDOL; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; LAXATIVE; METOCLOPRAMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; OPIATE; PHENOTHIAZINE DERIVATIVE; PROKINETIC AGENT; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROTECTIVE AGENT; PROTON PUMP INHIBITOR; SEDATIVE AGENT; SEROTONIN ANTAGONIST; SUCRALFATE; UNINDEXED DRUG;

CONSTIPATION; DIARRHEA; DRUG DISPOSITION; GASTRODUODENAL ULCER; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RECTAL DRUG ADMINISTRATION; REVIEW; STOMACH ACID SECRETION; SUBCONJUNCTIVAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; VESTIBULAR SYSTEM; VOMITING;

EID: 0032902887     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0195-5616(99)50026-0     Document Type: Review

References (97)

1. R. Albibi R.W. McCallum Metoclopramide: Pharmacology and cliriical application Arch Intern Med 98 1983 86 95
2. T.R. Ames E.B. Patterson Pharmacokinetics of a long-acting oxytetracycline injectable in healthy and diseased calves Proceedings of the 13th World Congress of Disease in Cattle, 1984 1984 931 935
3. T. Andersson Omeprazole drug interaction studies Clin Pharmacokinet 21 1991 195 212
4. P.I.R. Andrews W.G. Rapeport G. Sanger Neuropharmacology of emesis induced by anti-cancer therapy Trends in Pharmaceutical Sciences 9 1988 334 441
5. C.E. Atkins R. Tyler P. Greenlee Clinical, biochemical, acid–base, and electrolyte abnor- malities in cats after hypertonic sodium phosphate enema administration Am J Vet Res 46 1985 980 988
6. K.J. Baker Binding of sulfobromophthalein sodium and indocyanine green by plasma alpha 1 lipoproteins Proc Soc Exp Biol Med 122 1966 957 963
7. K. Bemis A. Bendele J. Clemens General pharmacology of nizatidine in animais Drug Res 39 1989 240 250
8. O.E. Brodde Vascular dopamine receptors: Démonstration and characterization by in vitro studies Life Sci 31 1982 289 306
9. R.N. Brogden A.A. Carminé R.C. Heel Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases Drugs 24 1982 267 303
10. L.L. Brunton Agents affecting gastrointestinal water flux and motility; Emesis and antiemetics; Bile acids and pancreatic enzymes J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics, ed 9 1995 McGraw-Hill New York 917 936
11. L.L. Brunton Agents for control of gastric acidity and treatment of peptic ulcers J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics, ed 9 1995 McGraw-Hill New York 901 916
12. C.F. Burrows Gastrointestinal pharmacology Proceedings of the American Animal Hospital Association Annual Meeting 1984 197 200
13. C.F. Burrows Metoclopramide Journal of the American Veterinary Médical Association 183 1983 1341 1343
14. C.F. Burrows Ondansetron: A new drug to control nausea and emesis in cancer patients Vet Clin Briefs 8 1990 3
15. M. Chiavarini E. Barocelli V. Ballabeni Omeprazole-like compounds on histamine- stimulated acid and peptic sécrétions in conscious dog and cat Boll Soc Ital Biol Sper 68 1992 429 436
16. N. Charlet H.E. Gallo-Torres Y. Bounameaux Prostaglandins and the protection of the gastroduodenal mucosa in humans: A critical review J Clin Pharmacol 25 1985 564 582
17. B. Costall R.J. Naylor Neuropharmacology of emesis in relation to clinical response Br J Cancer 19 suppl 1992 S2 7
18. A. Crema F. De Ponti Recent advances in the physiology of intestinal motility Pharmacol Res 21 1989 67 73
19. D.S. Dimski Constipation: Pathophysiology, diagnostic approach, and treatment Semin Vet Med Surg 4 1989 247 254
20. H.L. DuPont Bismuth subsalicylate in the treatment and prévention of diarrheal disease Ann Pharmacother 21 1987 687 693
21. 2-antago- nist withdrawal-a comparative study with nizatidine, ranitidine and famotidine Aliment Pharmacol Ther 5 1991 391 398
22. O. Furukawa H. Matsui N. Suzuki Effects of sucralfate and its components on acid- and pepsin-induced damage to rat gastric epithelial cells Jpn J Pharmacol 75 1997 21 25
23. 3 receptor antagonists: Review of preclinical and clinical results with ICS 205–930 Cancer Treat Rev 17 1990 301 305
24. M. Gibaldi Drug interactions: Part I Ann Pharmacother 26 1992 709 713
25. R.J. Gralla L.M. Itri S.E. Pisko Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy- induced nausea and vomiting N Engl J Med 305 1981 905 909
26. B. Greenwood J.S. Davison The relationship between gastrointestinal motility and sécrétion Am J Physiol 252 suppl 1987 Gl G7
27. S.R. Guharoy Streptokinase versus recombinant tissue-type plasminogen activator [ab- stract] Ann Pharmacother 25 1991 1271 1272
28. R.A. Hahn J.R. Wardell Antagonism of the rénal vasodilator activity of dopamine by metoclopramide Naunyn Schmiedebergs Arch Pharmacol 314 1980 177 182
29. A.R. Hickey T.L. Wenger V.P. Carpenter Digoxin immune fab therapy in the management of digitalis intoxication: Safety and efficacy results of an observational surveillance study J Am Coll Cardiol 17 1991 590 598
30. Y. Hikasa S. Ogasawara K. Takase Alpha adrenoceptor subtypes involved in the emetic action in dogs J Pharmacol Exp Ther 261 1992 746 754
31. Y. Hikasa K. Takase S. Ogasawara Evidence for the involvement of alpha-adrenoceptors in the emetic action of xylazine in cats Am J Vet Res 50 1989 1348 1350
32. B.I. Hirschowitz R.G. Gibson Effect of cimetidine on stimulated gastric sécrétion and sérum gastrin in the dog Am J Gastroenterol 70 1987 437 447
33. D. Hollander A. Tarnawski The protective and therapeutic mechanisms of sucralfate Scand J Gastroenterol 25 Suppl 173 1990 l 5
34. D. Horn The impact of fecal impactions Cornell Feline Health Center Information Bulletin 2 1987 1 8
35. 2-receptor antagonist: Comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome Gastroenterology 88 1985 1026 1033
36. S. Hughes Acute secretory diarrhoeas: Current concepts in pathogenesis and treatment Drugs 26 1983 80 90
37. Z. Itoh A. Mizumoto Y. Iwanaga Involvement of 5-hydroxytryptamine 3 receptors in régulation of interdigestive gastric contractions by motilin in the dog Gastroenterology 100 1991 901 908
38. J.E. Jackson Cimetidine protects against acetaminophen toxicity Life Sci 31 1982 31 35
39. J.E. Jackson Réduction of liver blood flow by cimetidine N Engl J Med 307 1981 99 101
40. C.J. Jenkins R.C. DeNovo Omeprazole-a new anti-ulcer agent Proc Am Coll Vet Med 8 1990 437 439
41. S.L. Jensen P.F. Jensen Rôle of sucralfate in peptic disease Dig Dis 10 1992 153 161
42. S.E. Johnson Clinical pharmacology of antiemetics and antidiarrheals Proceedings of the Kal Kan Waltham Symposium for the Treatment of Small Animal Diseases 1984 Columbus OH 7 15
43. J.B. Jones R.T. Bailey Jr. Misoprostol: A prostaglandin Ei analog with antisecretory and cytoprotective properties Ann Pharmacother 23 1989 276 282
44. P.O. Katz K.R. Geisinger M. Hassan Acid-induced esophagitis in cats is prevented by sucralfate but not synthetic prostaglandin E Dig Dis Sci 33 1988 217 224
45. R.L. Kleiman C.G. Adair K.S. Ephgrave Stress ulcers: Current understanding of patho- genesis and prophylaxis Ann Pharmacother 22 1988 452 460
46. 3) antagonist for antineoplastic chemotherapy-induced nausea and vomiting Ann Pharmacother 25 1991 367 380
47. S.J. Konturek T. Brzozowski D. Drozdowicz Rôle of acid milieu in the gastropro- tective and ulcer-healing activity of sucralfate Am J Med 91 Suppl 2A 1991 20S 29S
48. S.J. Konturek T. Brzozowski J. Majka Rôle of nitric oxide and prostaglandins in sucralfate-induced gastroprotection Eur J Pharmacol 211 1992 277 279
49. 2-receptor antagonists: Clinical pharmacokinetics and drug interaction potential Clin Pharmacokinet 15 1988 205 215
50. W. Kromer Endogenous and exogenous opioids in the control of gastrointestinal motility and sécrétion Pharmacol Rev 40 1988 121 162
51. T.A. Lampkin D. Ouellet L.J. Hak Omeprazole: A novel antisecretory agent for the treatment of acid-peptic disorders Ann Pharmacother 24 1990 393 402
52. 2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa Dig Dis Sci 37 1992 1029 1037
53. H. Larsson H. Mattsson E. Carlsson Gastric acid antisecretory effect of two différent dosage forms of omeprazole during prolonged oral treatment in the gastric fistula dog Scand J Gastroenterol 23 1988 1013 1019
54. A.R. Manara S. Bolsin C.R. Monk Metoclopramide and rénal vascular résistance J Anaesth 66 1991 129 130
55. L.N. Marks D.A. Johnston G.O. Young Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate Am J Med 91 Suppl 2A 1991 95S 100S
56. D.M. McCarthy Sucralfate Drug Therapy 325 1991 1017 1023
57. K.R. Merrifield B.J. Chaffee Recent advances in the management of nausea and vomiting caused by antineoplastic agents Clin Pharmacol 8 1989 187 199
58. T.A. Miller Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms Am J Physiol 245 suppl 1983 G601 G623
59. Misoprostol Preclinical and Clinical Review 1990 Physicians and Scientists Publishing Glenview, IL
60. K.J. Moreland Ulcer disease of the upper gastrointestinal tract in small animais: Patho- physiology, diagnosis and management Compend Contin Educ Pract Vet 10 1988 1265 1279
61. J.F. Morrissey R.F. Barreras Drug therapy, antacid therapy N Engl J Med 290 1974 550 554
62. W.W. Muir Small volume resuscitation using hypertonic saline Cornell Vet 80 1990 7 12
63. M.G. Papich C.A. Davis L.E. Davis Absorption of salicylate from an antidiarrheal préparation in cats and dogs J Am Anim Hosp Assoc 23 1987 221 228
64. H.P. Parkman A.P. Pagano J.P. Ryan Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms Dig Dis Sci 43 1998 497 505
65. H.P. Parkman J.L. Urbain L.C. Knight Effect of gastric acid suppressants on human gastric motility Gut 42 1998 243 250
66. S.J. Peroutka S.H. Snyder Antiemetics: Neurotransmitter receptor binding predicts thera- peutic actions Lancet 1 8273 1982 658 659
67. P. Pouderoux P.J. Kahrilas A comparative study of cisapride and ranitidine at controlling oesosophageal acid exposure in erosive oesophagitis Aliment Pharmacol Ther 9 1995 661 666
68. A.H. Price R.N. Brogden Nizatidine: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease Drugs 36 1988 521 539
69. J.C. Reynolds Prokinetic agents: A key in the future of gastroenterology Gastroenterol Clin North Am 18 1989 437 457
70. K.P. Richter Update on the use of newer gastrointestinal drugs in small animais Proc Am Coll Vet Med 8 1990 141 144
71. A. Robert Effect of drugs on gastric section L.R. Johnson Physiology of the Gastroenterology Tract, ed 2 1987 Raven Press New York 1071 1088
72. A. Robert G.L. Kauffman Jr. Stress ulcers, érosions and gastric mucosal injury M.H. Sleisenger J.S. Fordtran Gastrointestinal Diseases: Pathophysiology, Diagnosis, Management, ed 4 1989 WB Saunders Philadelphia 773 855
73. M.G. Robinson New oral salicylates in therapy of chronic idiopathic inflammatory bowel disease Gastroenterol Clin North Am 18 1989 43 50
74. L.R. Schiller C.A. Santa Ana S.G. Morawski Mechanism of the antidiarrheal effect of loperamide Gastroenterology 86 1984 1475 1480
75. A.J. Sedman Cimetidine-drug interactions Am J Med 76 1984 109 114
76. T. Shinkai N. Saijo K. Eguchi Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: A randomized controlled trial Jpn J Clin Oncol 19 1989 40 44
77. C.J. Shorrock W.D.W. Rees Overview of gastroduodenal mucosal protection Am J Med 84 Suppl 2A 1988 25 34
78. J.K. Siepler K. Mahakian W.T. Trudeau Current concepts in clinical therapeutics: Peptic ulcer disease Clin Pharmacol 5 1986 128 142
79. B.L. Slomiany J. Piotrowski A. Slomiany Cell cycle progression during gastric ulcer healing by ebrotidine and sucralfate Gen Pharmacol 29 1997 367 370
80. B.I. Slomiany J. Piotrowski S. Tamura Enhancement of the protective qualities of gastric mucus by sucralfate: Rôle of phosphoinositides Am J Med 91 Suppl 2A 1991 30S 36S
81. J.E. Sojka S.B. Adams C.H. Lamar Effect of butorphanol, pentazocine, meperidine, or metoclopramide on intestinal motility in female ponies Am J Vet Res 49 1988 527 529
82. W.M. Steinberg J.H. Lewis D.M. Katz Antacid inhibits absorption of cimetidine N Engl J Med 307 1982 400 404
83. S. Szabo P. Vattay E. Scarbough Rôle of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate Am J Med 91 Suppl 2A 1991 158S 160S
84. I. Szelenyi K. Brune Possible rôle of sulfhydryls in mucosal protection induced by aluminum hydroxide Dig Dis Sci 31 1986 1207 1210
85. T. Takahashi S. Kurosawa J.W. Wiley Mechanism for the gastrokinetic actions of domperidone Gastroenterology 101 1991 703 710
86. A. Tarnawski D. Hollander H. Gergely The mechanism of protective, therapeutic and prophylactic actions of sucralfate Scand J Gastroenterol 22 Suppl 140 1987 7 13
87. M.B. Tyers Pharmacology and preclinical antiemetic properties of ondansetron Semin Oncol 19 suppl 10 1992 1 8
88. M. Urbie A. Ballesteros R. Strauss Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease Gastroenterology 88 1985 757 762
89. H. Vergin C. Kori-Lindner Putative mechanisms of cytoprotective effect of certain antacids and sucralfate Dig Dis Sci 35 1990 1320 1327
90. K. Wada Y. Kamisaki M. Kitano Effects of sucralfate on acute gastric mucosal injury and gastric ulcer induced by ischemia-reperfusion in rats Pharmacology 54 1997 5763
91. W.A. Watson Factors influencing the clinical efficacy of activated charcoal Ann Pharmacother 21 1987 160 166
92. B.J.R. Whittle A. Garner New targets for anti-ulcer drugs Trends in Pharmaceutical Sciences 9 1988 187 189
93. J.R. Wilcke J.C. Turner The use of absorbents to treat gastrointestinal problems in small animais Semin Vet Med Surg 2 1987 266 273
94. D.E. Wilson Antisecretory and mucosal protective actions of misoprostol Am J Med 83 Suppl lA 1987 2 7
95. D. Wingate E. Pearce M. Hutton Effect of metoclopramide on interdigestive myoelectric activity in the conscious dog Dig Dis Sci 25 1980 15 21
96. M.M. Wolfe A.H. Soll The physiology of gastric acid sécrétion N Engl J Med 319 1989 1707 1715
97. Y. Yamaji T. Abe T. Omata Effects of successive doses of nizatidine, cimetidine and ranitidine on sérum gastrin level and gastric acid sécrétion Drug Res 41 1991 954 957